FDA-Approved Drugs

Currently, there are four cannabis-related drugs that are FDA-approved to treat seizures, nausea, and anorexia. Whether you’re looking into CBD oils and other hemp extracts because you have a serious illness, or you just want to know if CBD can help you sleep better, reduce a bit of anxiety, or alleviate nagging, chronic pain, this article may help you better understand how other people are using CBD and hemp oil.

Some Legal Stuff First

Before we get into all that, it’s important to know that currently, the FDA is waiting on more clinical evidence before they officially approve CBD to treat the conditions in this article. In the meantime, just know that it’s illegal for a distributor/company to claim that CBD oil can cure or treat a condition not described in the FDA-approved list.

However, there is not only anecdotal evidence, but a growing collection of scientific studies from across the globe involving CBD oil and hemp extracts. Word has gotten out that CBD might help with your anxiety, insomnia or chronic pain. So, let’s take a look at some of the common conditions that people use CBD products to treat.

CBD for Pain

There have been numerous studies that point to CBD oil’s effectiveness in decreasing pain. [4] Since endocannabinoid system receptors are found near nerve cells that receive pain signals, scientists have taken a closer look at how CBD affects these cells. A Canadian study suggests that CBD stops the sodium channels on the nerve cells from firing, thus stopping the signal of pain. [5] This makes sense since CBD has already been proven to be an anti-seizure drug. Seizures are simply nerves that fire uncontrollably in the brain.

CBD for Anxiety

Scientists in the psychiatry and psychology fields are very interested in the anti-anxiety and anti-fear effects that CBD has on those suffering from panic attacks and severe anxiety. A recent study, published in April of 2019, showed that CBD suppressed the part of the brain that contains traumatizing memories. [6] This study is promising because many disorders have their root cause in past fears: PTSD, anxiety, and other trauma-related mental illnesses.

CBD for Insomnia

Good sleep is regulated by the brain. A 2017 study showed that both CBD oil and THC are effective at reducing nightmares, increasing REM cycles, and helping people fall asleep faster. [7] Since the endocannabinoid system helps regulate the nervous system, it’s no wonder that CBD has an effect on all things controlled by the brain.

Shopping for Reputable CBD Products

If you’re ready to give CBD a try, you’re in luck. The good news is, the prevalence of this hemp extract means that it’s more available than ever. The less-than-good news is that it’s becoming more easier for unscrupulous people to slap a label on some pretty crummy products.

The Hemp Experts at Maven have sourced the highest-quality raw materials to create their hemp extracts and CBD isolate. All Maven products are Lab-Tested by reputable, independent third-party labs and are guaranteed less than 0.3% THC. We also make it super-simple to hone in on the best dosage by partnering with GoFire; a technology company from Colorado. Simply download the GoFire app, scan the DoseCode (QR) on your Maven CBD product and you’re on your way to relief.

References

  1. Commissioner, O. of the. (n.d.). FDA Regulation of Cannabis and Cannabis-Derived Products: Q&A. Retrieved October 7, 2019, from https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#approved.
  2. Marinol, Syndros (dronabinol) dosing, indications, interactions, adverse effects, and more. (2019, September 28). Retrieved October 7, 2019, from https://reference.medscape.com/drug/marinol-syndros-dronabinol-342047#10.
  3. Cesamet. (2006, May). Retrieved October 7, 2019, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s011lbl.pdf
  4. Urits, I., Borchart, M., Hasegawa, M., Kochanski, J., Orhurhu, V., & Viswanath, O. (2019). An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. Pain and therapy, 8(1), 41–51. doi:10.1007/s40122-019-0114-4
  5. Watkins A. R. (2019). Cannabinoid interactions with ion channels and receptors. Channels (Austin, Tex.), 13(1), 162–167. doi:10.1080/19336950.2019.1615824
  6. Papagianni, E. P., & Stevenson, C. W. (2019). Cannabinoid Regulation of Fear and Anxiety: an Update. Current psychiatry reports, 21(6), 38. doi:10.1007/s11920-019-1026-z
  7. Babson, K.A., Sottile, J. & Morabito, D. Curr Psychiatry Rep (2017) 19: 23. https://doi.org/10.1007/s11920-017-0775-9